New England Journal of Medicine Publishes Latest Sheba Insights Into Chronic Kidney Disease
Sheba strives to remain at the forefront of medical research and is proud to announce the publication of a significant review article in the New England Journal of Medicine (NEJM), one of the most prestigious medical journals worldwide.
Genetic Insights into Chronic Kidney Disease
Chronic kidney disease (CKD) affects more than 800 million people worldwide, yet many of the causes of CKD are difficult to identify through traditional clinical diagnostics. Furthermore, it is estimated that 30-50% of CKD cases among children and 10-20% among adults can be explained through monogenic disorders.
Penned by Prof. Asaf Vivante, Directorof the Department of Pediatrics B and the Genetic Kidney Disease Research Laboratory at Sheba, the article comprehensively examines the genetic factors contributing to chronic kidney disease.
Advancing CKD Care Through Genetic Diagnosis and Treatment
Providing physicians with a foundational understanding of the contribution of genetic diseases to CKD among children and adults, the review explores the latest advances in CKD genetic diagnosis and management and the contribution of variants that confer a substantial risk of progressive CKD.
“Research into chronic kidney disease genetics has significantly advanced over the last few decades. Today physicians can provide a genetic-molecular diagnosis, establishing a precise cause for the disease and allowing personalized monitoring and treatment accompanied by genetic counseling,” said Prof. Asaf Vivante. “My hope is that physicians will use this review article to learn more about the current state of chronic kidney disease research and enable patients to access the latest advances in genetic-based diagnosis and treatment.”
More Posts
Sheba’s Physicians Sweep Forbes Israel’s 2025 “Best Doctors” List
Forbes Israel has named an exceptional number of Sheba Medical Center’s physicians on its 2025 “Best Doctors” list. Earlier this year, Sheba was ranked by Newsweek as one of the World’s Top 10 Hospitals. This recognition and alignment between institutional and individual excellence signals to the global medical community that Sheba concentrates many of Israel’s most trusted clinical leaders under one roof.
Twinning and Training: Scalable Solutions for Global Eye Cancer Equity
Sheba Global Ophthalmology (SGO) demonstrates how sustainable twinning and hands-on training create self-reliant ocular oncology capacity in low- and middle-income countries (LMICs), far surpassing the limitations of short-term outreach.
ARC Launches HaMeirim: Sheba’s New Cardiovascular Innovation Center
Sheba Medical Center’s ARC innovation arm has launched and inaugurated HaMeirim – ARC Cardiovascular (“The Radiant Ones” or “Those who shine”), a dedicated innovation center for the Heart, Thorax, and Vascular Center.
